ofloxacin and amikacin

ofloxacin has been researched along with amikacin in 109 studies

Research

Studies (109)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (3.67)	18.7374
1990's	17 (15.60)	18.2507
2000's	39 (35.78)	29.6817
2010's	42 (38.53)	24.3611
2020's	7 (6.42)	2.80

Authors

Authors	Studies
Cho, SH; Franzblau, SG; Hwang, CH; Pauli, GF; Wan, B; Warit, S	1
Caniça, M; Ferreira, E; Leitão, J; Manageiro, V; Mendonça, N	1
Amblard, M; Bastide, L; Gualtieri, M; Leonetti, JP; Martinez, J; Pugniere, M; Roquet, F; Villain-Guillot, P	1
Bouza, E; Cercenado, E; Coll, P; Gutiérrez, O; Juan, C; Navarro, F; Oliver, A; Pérez, JL	1
Andres, P; Centrón, D; Galas, M; Guerriero, L; Petroni, A; Quiroga, C; Quiroga, MP; Soler Bistué, AJ; Tokumoto, M; Tolmasky, ME; Vargas, LJ; Zorreguieta, A	1
Lombardo, F; Obach, RS; Waters, NJ	1
Badur, S; Cagatay, AA; Carrër, A; Eraksoy, H; Nordmann, P; Poirel, L	1
Cattoir, V; Nordmann, P; Poirel, L	1
Connell, TG; Curtis, N; Ritz, N; Robins-Browne, R; Sievers, A; Tebruegge, M	1
Kirikae, T; Kitao, T; Miyoshi-Akiyama, T	1
Govender, K; Govender, P; Govender, T; Kruger, HG; Maguire, GE; Muthusamy, K; Onajole, OK; Pillay, M; van Helden, PD; Wiid, I	1
Girlich, D; Nordmann, P; Poirel, L	1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
Blango, MG; Mulvey, MA	1
Khanna, A; Pareek, PK; Raj, VS; Rattan, A; Saini, KS; Sharma, P; Singh, H; Sood, R; Tarai, B; Upadhyay, DJ	1
Glen, RC; Lowe, R; Mitchell, JB	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Cai, G; Cho, S; Franzblau, SG; Jaki, BU; Lee, IA; McAlpine, JB; Napolitano, JG; Pauli, GF; Suh, JW; Wang, Y; Yang, SH	1
Dufková, I; Hrabálek, A; Karabanovich, G; Klimešová, V; Němeček, J; Pávek, P; Roh, J; Smutný, T; Stolaříková, J; Vávrová, K; Vejsová, M; Vicherek, P	1
Álvarez, A; Arocha, I; Chávez, K; Compagnone, RS; Figarella, K; Galindo-Castro, I; Marsiccobetre, S; Orsini, G; Suárez, AI; Taddei, A; Tillett, S; Triviño, J	1
Dixit, PP; Thore, SN	1
Centárová, I; Cole, ST; Čonka, P; Hrabálek, A; Karabanovich, G; Klimešová, V; Mikušová, K; Němeček, J; Pávek, P; Pávková, I; Roh, J; Šarkan, M; Smutný, T; Stolaříková, J; Székely, R; Vávrová, K; Vejsová, M; Vocat, A; Zemanová, J	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Dwoskin, LP; Garneau-Tsodikova, S; Green, KD; Kril, LM; Kwiatkowski, S; Nickell, JR; Shrestha, SK; Sviripa, VM; Watt, DS	1
Carazo, A; Hrabálek, A; Karabanovich, G; Klimešová, V; Konečná, K; Němeček, J; Pávek, P; Pavliš, O; Roh, J; Stolaříková, J; Valášková, L; Vávrová, K	1
Carazo, A; Hrabálek, A; Karabanovich, G; Klimešová, V; Němeček, J; Pávek, P; Pavliš, O; Roh, J; Stolaříková, J; Sychra, P; Valášková, L; Vávrová, K; Vlčková, H	1
Bishai, WR; Duan, G; Gunosewoyo, H; Liu, LL; Lun, S; Tang, J; Xiao, S; Yang, F; Yu, LF; Zhang, W	1
Bera, S; Mondal, D	1
Dušek, J; Hrabálek, A; Huszár, S; Jand'ourek, O; Karabanovich, G; Klimešová, V; Kočová Vlčková, H; Konečná, K; Konyariková, Z; Korábečný, J; Korduláková, J; Kučera, T; Mikušová, K; Pávek, P; Pávková, I; Pavliš, O; Roh, J; Savková, K; Stolaříková, J; Vávrová, K	1
Alonso-Rodriguez, N; Briffotaux, J; Buchieri, MV; Cimino, M; Coulibaly, S; Dallemagne, P; Gicquel, B; Lecoutey, C; Mornico, D; Ouattara, M; Rochais, C	1
Abbas, Z; Karim, M; Malik, IA	1
Akalin, HE; Gür, D; Kocagöz, T	1
Beaucaire, G; Beuscart, C; Caillaux, M; Chidiac, C; Karp, P; Leroy, O	1
Karahan, M; Kiliç, H	1
Hayran, M; Kocagöz, T; Sener, B; Ustaçelebi, S	1
Dellamonica, P; Drugeon, HB; Etesse, H; Garraffo, R; Lapalus, P	1
Aydin, M; Dervişoğlu, AA; Unal, S	1
Aung-khin, M; Kwan, SY; Ma, WK; Mok, CK; Yew, WW	1
de Micco, P; Gevaudan, MJ; Gulian, C; Lagier, P; Mallet, MN; Terriou, P	1
Gulden, H; Kern, W; Kurrle, E; Vanek, E	1
Bryskier, A; Goh, KS; Rastogi, N	1
Bhagat, R; Panchal, N; Shah, A	1
Chan, CY; Cheng, AF; Li, MS; Tsui, SY; Yew, WW	1
Bryskier, A; Devallois, A; Goh, KS; Rastogi, N	1
Hanberger, H; Nilsson, LE; Svensson, E	1
Furukawa, T; Komachi, H; Nagai, R; Saito, Y; Takewaki, S; Uchihara, T	1
Appelbaum, PC; Bajaksouzian, S; Jacobs, MR; Visalli, MA	1
Krcmery, V; Krupova, Y; Mateicka, F; Novotny, J; Sabo, A	1
Colomer, R; Cortés-Funes, H; García-Carbonero, R; Gómez, C; Hidalgo, M; Hornedo, J; Lumbreras, C; Perea, S; Ruiz, A; Trigo, JM	1
Martínek, J; Melenovsky, V; Morávek, J; Spicák, J; Závada, F	1
Chen, M; Qian, H; Zhang, Y	1
Mayer, I; Nagy, E	1
Bryskier, A; Carbon, C; Farinotti, R; Joly-Guillou, ML; Wolff, M	1
Berning, SE; Cherry, TA; Iseman, MD	1
Aguilar, R; Auclair, B; Maslow, JN; Mikota, SK; Peloquin, CA	1
Dailloux, M; Dauendorffer, JN; Laurain, C; Weber, M	1
Cabria, F; Esteban, J; Fernández-Roblas, R; Gadea, I; Rollan, E; Santos-O'Connor, FG; Soriano, F; Torres, MV	1
Matoba, AY	1
Derevianko, II	1
Kam, KM; Yip, CW	1
Andrianasolo, D; Ramarokoto, H; Ramaroson, F; Rasolofo Razanamparany, V; Rasolonavalona, T; Ratsimba, L; Razafitsiarovana, I; Vincent, V	1
Arjratanakool, W; Asawapokee, N; Chaiprasert, A; Dhiraputra, C; Leechawengwong, M; Leelarasamee, A; Prammananan, T; Tingtoy, N	1
Jin, X; Li, R; Liang, Q; Luo, S; Sun, X; Wang, Z	1
De Vecchi, E; Drago, L; Gismondo, MR; Nicola, L; Tocalli, L	1
Bramhne, HG; Chhibber, S; Sharma, S; Toky, V	1
Felici, A; Guerrini, M; Marchetti, F; Piccoli, L	1
Marchetti, F; Mingoia, M; Montanari, MP; Piccoli, L; Varaldo, PE	1
Farnia, P; Khoshnood, K; Mansoori, SD; Masjedi, H; Masjedi, MR; Mirsaeidi, SM; Mohammadi, F; Pooramiri, MV; Rowhani-Rahbar, A; Tabarsi, P; Velayati, AA; Zahirifard, S	1
Bory, AM; Chevalier-Evain, V; Mubiayi, N; Orazi, G; Therby, D	1
Agrawal, C; Datta, V; Kumar, A; Mehta, G; Randhawa, VS; Saili, A	1
De Vecchi, E; Drago, L; Gismondo, MR; Nicola, L	1
Chang, KT; Hou, JG; Kwa, AL; Ledesma, KR; Lim, TP; Nikolaou, M; Prince, RA; Quinn, JP; Tam, VH	1
Béraud, G; Iba Ba, J; Legout, L; Mouton, Y; Senneville, E; Yazdanpanah, Y	1
Braker, K; Cox, HS; Feuerriegel, S; Karimovich, HA; Niemann, S; Rüsch-Gerdes, S; Zarkua, N	1
Barnini, S; Barra, D; Batoni, G; Brancatisano, FL; Campa, M; Capria, AL; Di Luca, M; Esin, S; Maisetta, G; Mangoni, ML; Pichierri, G	1
Ermertcan, S; Hosgor-Limoncu, M; Tasli, H; Yurtman, AN	1
Agarwala, S; Bakhshi, S; Gupta, A; Pandey, RM; Swaroop, C	1
Bonato, D; Desmond, E; Gross, W; Lin, SY; Siddiqi, S	1
Cheng, L; Congdon, N; Lam, PT; Tam, PM; Young, AL	1
Hou, J; Ledesma, KR; Prince, RA; Singh, R; Tam, VH; Yuan, Z	1
Amiri, M; Baghaei, P; Caminero, JA; Chitsaz, E; Farnia, P; Kazempour, M; Mansouri, D; Marjani, M; Masjedi, MR; Shamaei, M; Tabarsi, P; Velayati, AA	1
Caminero, JA; Migliori, GB; Sotgiu, G; Zumla, A	1
Campbell, PJ; Cowan, LS; Dalton, TL; Hooks, DP; Metchock, B; Morlock, GP; Plikaytis, BB; Posey, JE; Sikes, RD; Starks, AM	1
Davies, T; Decker-Burgard, S; Körber-Irrgang, B; Kresken, M; Läuffer, J	1
Bompolaki, I; Bozionelou, V; Falagas, ME; Kalpadaki, C; Karageorgopoulos, DE; Koutsounaki, E; Mitsikostas, P; Samonis, G; Sgouros, J; Taktikou, V	1
Hsu, LY; Kwa, AL; Lee, W; Lim, TP; Sasikala, S; Syahidah, N; Tan, TT; Tan, TY; Teo, J	1
Anthony, RM; Bergval, I; Bosman, M; Böttger, EC; Coetzee, G; Dheda, K; Gey van Pittius, NC; Streicher, EM; van Helden, PD; Victor, TC; Warren, RM	1
Barnard, M; Bosman, M; Coetzee, G; Gey Van Pittius, N; O'Brien, R; Streicher, E; van Helden, P; Warren, R	1
Banavaliker, JN; Behera, D; Bhatnagar, AK; Hanif, M; Kaushik, A; Makkar, N; Pande, JN; Porwal, C; Singh, UB; Singla, R	1
Choe, KH; Chung, GT; Hwang, SC; Jnawali, HN; Kim, H; Lee, YS; Park, YK; Ryoo, S	1
Aubry, A; Brossier, F; Chauffour, A; Fillion, A; Jarlier, V; Veziris, N	1
Chen, X; Huang, H; Jiang, GL; Kam, KM; Song, Y; Zhao, Y	1
Gratz, J; Heysell, SK; Houpt, ER; Kibiki, GS; Kumburu, H; Mpagama, SG; Ndusilo, N; Peloquin, CA; Stroup, S	1
Ajbani, K; Catanzaro, A; Caviedes, L; Coronel, J; Crudu, V; Desmond, E; Eisenach, K; Ganiats, TG; Garfein, RS; Groessl, EJ; Jackson, RL; Klages, S; Moore, D; Rodrigues, C; Rodwell, TC; Romancenco, E; Trollip, AP; Victor, T; Vineet, VP	1
Alkhovik, OI; Cherednichenko, AG; Dymova, MA; Filipenko, ML; Khrapov, EA; Petrenko, TI	1
Augustynowicz-Kopeć, E; Bakuła, Z; Bielecki, J; Jagielski, T; Kamiński, M; Napiórkowska, A; Zwolska, Z	1
Debata, NK; Jena, J; Sahoo, RK; Subudhi, E	1
Chen, ST; Huang, HR; Jiang, GL; Ma, YF; Wang, GR; Yu, X	1
Cai, X; Deng, Y; Dong, H; Huan, S; Jing, H; Li, J; Li, Q; Li, X; Ou, X; Pang, Y; Su, B; Tan, Y; Xia, H; Zhang, J; Zhang, Z; Zhao, Y	1
Forsman, LD; Hoffner, S; Hu, Y; Mansjö, M; Werngren, J; Xu, B; Zheng, R; Zheng, X	1
Charof, R; Cherki, W; Ennassiri, W; Filali-Maltouf, A; Jaouhari, S; Lahlou, O	1
Bourkadi, JE; Chaoui, I; Chetioui, F; El Mzibri, M; Elmessaoudi, MD; Karimi, H; Laglaoui, A; Oudghiri, A; Zakham, F	1
Abdelwahab, SI; Dafalla, OME; Homeida, HE; Taha, MME	1
Gao, R; Guo, Y; Shen, X; Tan, G; Wang, H; Wu, X; Wu, Z; Yang, J; Yu, F	1
Jafari, R; Moghim, S; Nasr Esfahani, B; Safari, M; Salehi, M	1
Guo, Y; Liu, H; Sha, W; Shen, H; Shen, X; Tan, G; Wu, X; Wu, Z; Yang, J; Yu, F	1
Guo, Y; Huang, C; Sha, W; Tan, G; Wu, X; Yang, J; Yu, F	1
Bor, J; de Vos, M; Dolby, T; Horsburgh, CR; Jacobson, KR; Jenkins, HE; Leavitt, SV; Streicher, EM; Sy, KTL; Warren, RM	1
Anderson, K; Bian, A; Cox, H; Dheda, K; Pietersen, E; Shepherd, BE; Sterling, TR; van der Heijden, YF; Warren, RM	1

Reviews

3 review(s) available for ofloxacin and amikacin

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Insights of synthetic analogues of anti-leprosy agents. Bioorganic & medicinal chemistry, 2019, 07-01, Volume: 27, Issue:13 Topics: Humans; Leprostatic Agents; Leprosy; Structure-Activity Relationship	2019
Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis. The Lancet. Infectious diseases, 2010, Volume: 10, Issue:9 Topics: Amikacin; Antitubercular Agents; Capreomycin; Drug Resistance, Multiple; Ethambutol; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; Isoniazid; Kanamycin; Levofloxacin; Ofloxacin; Pyrazinamide; Tuberculosis	2010

Trials

7 trial(s) available for ofloxacin and amikacin

Article	Year
Randomised comparison of oral ofloxacin alone with combination of parenteral antibiotics in neutropenic febrile patients. Lancet (London, England), 1992, May-02, Volume: 339, Issue:8801 Topics: Administration, Oral; Adult; Amikacin; Anti-Bacterial Agents; Carbenicillin; Cloxacillin; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Male; Neutropenia; Ofloxacin; Piperacillin; Prospective Studies	1992
Clinical and bacteriological efficacy, and practical aspects of amikacin given once daily for severe infections. The Journal of antimicrobial chemotherapy, 1991, Volume: 27 Suppl C Topics: Adult; Aged; Amikacin; Bacterial Infections; Cefotaxime; Ceftazidime; Cross Infection; Drug Administration Schedule; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Male; Middle Aged; Ofloxacin; Piperacillin; Prospective Studies	1991
A new approach to optimal antibiotic dosage regimen by coupling pharmacokinetics and killing curve parameters. Methods and findings in experimental and clinical pharmacology, 1990, Volume: 12, Issue:5 Topics: Amikacin; Anti-Bacterial Agents; Cell Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Escherichia coli; Glycopeptides; Humans; Ofloxacin; Pseudomonas aeruginosa; Staphylococcal Infections; Staphylococcus epidermidis; Teicoplanin	1990
Outpatient therapy with oral ofloxacin for patients with low risk neutropenia and fever: a prospective, randomized clinical trial. Cancer, 1999, Jan-01, Volume: 85, Issue:1 Topics: Administration, Oral; Adult; Aged; Ambulatory Care; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Hospitalization; Humans; Injections, Intravenous; Male; Middle Aged; Neoplasms; Neutropenia; Ofloxacin; Prospective Studies; Treatment Outcome	1999
[Bronchofiberscope and catheter intervention in treatment of multi-drug resistant pulmonary tuberculosis]. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 1997, Volume: 20, Issue:6 Topics: Adult; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bronchoscopy; Catheterization, Peripheral; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Ofloxacin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	1997
Treatment of multiple drug-resistant tuberculosis (MDR-TB) in Iran. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2005, Volume: 9, Issue:6 Topics: Adolescent; Adult; Aged; Amikacin; Antitubercular Agents; Cycloserine; Drug Therapy, Combination; Female; Humans; Iran; Isoniazid; Male; Middle Aged; Ofloxacin; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2005
Randomized controlled trial comparing oral amoxicillin-clavulanate and ofloxacin with intravenous ceftriaxone and amikacin as outpatient therapy in pediatric low-risk febrile neutropenia. Journal of pediatric hematology/oncology, 2009, Volume: 31, Issue:9 Topics: Administration, Oral; Adolescent; Ambulatory Care; Amikacin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Ceftriaxone; Child; Child, Preschool; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Male; Neoplasms; Neutropenia; Ofloxacin; Treatment Outcome	2009

Other Studies

99 other study(ies) available for ofloxacin and amikacin

Article	Year
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:4 Topics: Anti-Bacterial Agents; Antitubercular Agents; DNA, Bacterial; Drug Evaluation, Preclinical; Mycobacterium tuberculosis; Oxygen	2007
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:6 Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Middle Aged; Portugal	2007
Structure-activity relationships of phenyl-furanyl-rhodanines as inhibitors of RNA polymerase with antibacterial activity on biofilms. Journal of medicinal chemistry, 2007, Aug-23, Volume: 50, Issue:17 Topics: Animals; Anti-Bacterial Agents; Biofilms; CHO Cells; Cricetinae; Cricetulus; DNA-Directed RNA Polymerases; Furans; Gram-Positive Bacteria; Microbial Sensitivity Tests; Rhodanine; Staphylococcus epidermidis; Structure-Activity Relationship	2007
Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:12 Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Chromosomes, Bacterial; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Integrons; Molecular Epidemiology; Molecular Sequence Data; Mutation; Plasmids; Polymerase Chain Reaction; Porins; Pseudomonas aeruginosa; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Spain	2007
Complex class 1 integrons with diverse variable regions, including aac(6')-Ib-cr, and a novel allele, qnrB10, associated with ISCR1 in clinical enterobacterial isolates from Argentina. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:12 Topics: Alleles; Amino Acid Sequence; Argentina; Bacterial Proteins; Base Sequence; beta-Lactamases; Cross Infection; DNA Transposable Elements; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Integrons; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Analysis, DNA; Sequence Homology, Nucleic Acid	2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:8 Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Genetic; Turkey	2008
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:10 Topics: Aged; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fluoroquinolones; France; Genes, Bacterial; Humans; Models, Genetic; Molecular Sequence Data; Plasmids	2008
Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:1 Topics: Antitubercular Agents; BCG Vaccine; Microbial Sensitivity Tests; Mycobacterium bovis	2009
AAC(6')-Iaf, a novel aminoglycoside 6'-N-acetyltransferase from multidrug-resistant Pseudomonas aeruginosa clinical isolates. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:6 Topics: Acetylation; Acetyltransferases; Aminoglycosides; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Integrons; Microbial Sensitivity Tests; Pseudomonas aeruginosa	2009
Pentacyclo-undecane derived cyclic tetra-amines: synthesis and evaluation as potent anti-tuberculosis agents. European journal of medicinal chemistry, 2009, Volume: 44, Issue:11 Topics: Alkanes; Animals; Antitubercular Agents; Cattle; Cell Line; Cell Survival; Inhibitory Concentration 50; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Prenylation	2009
First isolation of the blaOXA-23 carbapenemase gene from an environmental Acinetobacter baumannii isolate. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:1 Topics: Acinetobacter baumannii; beta-Lactamases; DNA, Bacterial; Escherichia coli; France; Genes, Bacterial; Water Microbiology	2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008
Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5 Topics: Animals; Anti-Bacterial Agents; Biofilms; Cell Membrane Permeability; Cells, Cultured; Drug Resistance, Bacterial; Endosomes; Escherichia coli; Escherichia coli Infections; Female; Humans; Mice; Mice, Inbred CBA; Microbial Sensitivity Tests; Recurrence; Urinary Bladder; Urinary Tract Infections; Urothelium	2010
Emergence and molecular characterization of extensively drug-resistant Mycobacterium tuberculosis clinical isolates from the Delhi Region in India. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:11 Topics: Amikacin; Antitubercular Agents; Bacterial Proteins; Capreomycin; DNA Gyrase; DNA Mutational Analysis; DNA-Directed RNA Polymerases; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; India; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Point Mutation; Polymerase Chain Reaction; Rifampin	2010
Predicting phospholipidosis using machine learning. Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5 Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine	2010
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Hytramycins V and I, anti-Mycobacterium tuberculosis hexapeptides from a Streptomyces hygroscopicus strain. Journal of natural products, 2013, Nov-22, Volume: 76, Issue:11 Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Chromatography, High Pressure Liquid; Inhibitory Concentration 50; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nuclear Magnetic Resonance, Biomolecular; Peptides, Cyclic; Streptomyces; Vero Cells	2013
1-Substituted-5-[(3,5-dinitrobenzyl)sulfanyl]-1H-tetrazoles and their isosteric analogs: A new class of selective antitubercular agents active against drug-susceptible and multidrug-resistant mycobacteria. European journal of medicinal chemistry, 2014, Jul-23, Volume: 82 Topics: Antineoplastic Agents; Antitubercular Agents; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Drug Screening Assays, Antitumor; HeLa Cells; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nitrobenzenes; Structure-Activity Relationship; Triazoles; Tumor Cells, Cultured	2014
Synthesis and biological evaluation of caracasine acid derivatives. Bioorganic & medicinal chemistry, 2015, Jul-01, Volume: 23, Issue:13 Topics: Amides; Anti-Bacterial Agents; Antineoplastic Agents; Antiprotozoal Agents; Bacillus cereus; Carboxylic Acids; Cell Line, Tumor; Cell Survival; Epoxy Compounds; Escherichia coli; Esters; Humans; Inhibitory Concentration 50; Leishmania mexicana; MCF-7 Cells; Phenanthrenes; Pseudomonas aeruginosa; Staphylococcus aureus; Structure-Activity Relationship; Trypanosoma cruzi	2015
Hybrid triazoles: Design and synthesis as potential dual inhibitor of growth and efflux inhibition in tuberculosis. European journal of medicinal chemistry, 2016, Jan-01, Volume: 107 Topics: Antitubercular Agents; Cells, Cultured; Chemistry Techniques, Synthetic; Drug Design; Drug Evaluation, Preclinical; Drug Synergism; Extensively Drug-Resistant Tuberculosis; Humans; Macrophages; Microbial Sensitivity Tests; Mycobacterium smegmatis; Mycobacterium tuberculosis; Triazoles	2016
Development of 3,5-Dinitrobenzylsulfanyl-1,3,4-oxadiazoles and Thiadiazoles as Selective Antitubercular Agents Active Against Replicating and Nonreplicating Mycobacterium tuberculosis. Journal of medicinal chemistry, 2016, Mar-24, Volume: 59, Issue:6 Topics: Animals; Antitubercular Agents; Bacteria; Cell Line; Cell Survival; Drug Design; Drug Resistance, Multiple, Bacterial; Fungi; Humans; Latent Tuberculosis; Microbial Sensitivity Tests; Microsomes; Mutagens; Mycobacterium tuberculosis; Oxazoles; Primary Cell Culture; Rifampin; Structure-Activity Relationship; Thiadiazoles	2016
Bis(N-amidinohydrazones) and N-(amidino)-N'-aryl-bishydrazones: New classes of antibacterial/antifungal agents. Bioorganic & medicinal chemistry, 2017, 01-01, Volume: 25, Issue:1 Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Bacterial Infections; Candida albicans; Candidiasis; Cell Line; Drug Discovery; Drug Resistance, Multiple; Fungi; Humans; Hydrazones; Microbial Sensitivity Tests; Mycoses	2017
S-substituted 3,5-dinitrophenyl 1,3,4-oxadiazole-2-thiols and tetrazole-5-thiols as highly efficient antitubercular agents. European journal of medicinal chemistry, 2017, Jan-27, Volume: 126 Topics: Antifungal Agents; Antitubercular Agents; Drug Design; Drug Resistance; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Oxadiazoles; Structure-Activity Relationship; Sulfhydryl Compounds; Tetrazoles	2017
Development of water-soluble 3,5-dinitrophenyl tetrazole and oxadiazole antitubercular agents. Bioorganic & medicinal chemistry, 2017, 10-15, Volume: 25, Issue:20 Topics: Antitubercular Agents; Caco-2 Cells; Cell Line; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Oxadiazoles; Solubility; Structure-Activity Relationship; Tetrazoles; Water	2017
Identification of Novel Coumestan Derivatives as Polyketide Synthase 13 Inhibitors against Mycobacterium tuberculosis. Part II. Journal of medicinal chemistry, 2019, 04-11, Volume: 62, Issue:7 Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Coumarins; Crystallography, X-Ray; Drug Resistance, Bacterial; Enzyme Inhibitors; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Polyketide Synthases; Structure-Activity Relationship; Vero Cells	2019
Development of 3,5-Dinitrophenyl-Containing 1,2,4-Triazoles and Their Trifluoromethyl Analogues as Highly Efficient Antitubercular Agents Inhibiting Decaprenylphosphoryl-β-d-ribofuranose 2'-Oxidase. Journal of medicinal chemistry, 2019, 09-12, Volume: 62, Issue:17 Topics: Alcohol Oxidoreductases; Antitubercular Agents; Bacterial Proteins; Dinitrobenzenes; Dose-Response Relationship, Drug; Drug Development; Hydrocarbons, Fluorinated; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Triazoles	2019
Phenanthrolinic analogs of quinolones show antibacterial activity against M. tuberculosis. European journal of medicinal chemistry, 2020, Dec-01, Volume: 207 Topics: Antitubercular Agents; Drug Design; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Phenanthrolines; Quinolones	2020
[In vitro activity of various antibiotic agents against gram-negative nosocomial bacteremia pathogens]. Mikrobiyoloji bulteni, 1992, Volume: 26, Issue:3 Topics: Amikacin; Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Cross Infection; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Ofloxacin	1992
[In vitro sensitivity of gram-negative bacteria isolated from urinary tract infections to various antibiotics]. Mikrobiyoloji bulteni, 1991, Volume: 25, Issue:1 Topics: Amikacin; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ceftazidime; Clavulanic Acids; Drug Therapy, Combination; Enterobacter; Enterobacteriaceae; Escherichia coli; Gram-Negative Bacteria; Humans; Klebsiella; Ofloxacin; Piperacillin; Proteus; Pseudomonas; Turkey; Urinary Tract Infections	1991
[The in vitro activity of ciprofloxacin against clinically-isolated strains of Pseudomonas aeruginosa and comparison with some other antibiotics]. Mikrobiyoloji bulteni, 1990, Volume: 24, Issue:2 Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Aztreonam; Ceftriaxone; Ciprofloxacin; Gentamicins; Humans; Ofloxacin; Pseudomonas aeruginosa	1990
[An epidemiologic study of the antibiotic susceptibility of bacteria isolated from patients with urinary tract infections]. Mikrobiyoloji bulteni, 1989, Volume: 23, Issue:4 Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Bacteria; Cefotaxime; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Ofloxacin; Prevalence; Turkey; Urinary Tract Infections	1989
Combination of ofloxacin and amikacin in the treatment of sternotomy wound infection. Chest, 1989, Volume: 95, Issue:5 Topics: Adult; Aged; Amikacin; Cardiac Surgical Procedures; Drug Combinations; Female; Humans; Injections, Intramuscular; Injections, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Ofloxacin; Sternum; Surgical Wound Infection	1989
[Sensitivity of 7 mycobacterial species to new quinolones]. Pathologie-biologie, 1988, Volume: 36, Issue:5 Topics: Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Drug Combinations; Drug Synergism; Erythromycin; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium avium; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Sulfamethoxazole; Thienamycins; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination	1988
In vitro antibacterial activity of imipenem in combination with newer quinolone derivatives. Chemotherapy, 1988, Volume: 34, Issue:2 Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Drug Evaluation, Preclinical; Drug Interactions; Drug Resistance, Microbial; Humans; Imipenem; Norfloxacin; Ofloxacin; Oxazines; Thienamycins	1988
Activities of roxithromycin used alone and in combination with ethambutol, rifampin, amikacin, ofloxacin, and clofazimine against Mycobacterium avium complex. Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:6 Topics: Amikacin; Clofazimine; Drug Synergism; Ethambutol; Humans; Microbial Sensitivity Tests; Mycobacterium avium Complex; Ofloxacin; Rifampin; Roxithromycin	1994
Resistant tuberculosis: successful treatment with amikacin, ofloxacin, clofazimine, and pas. Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 1993, Volume: 74, Issue:1 Topics: Adult; Amikacin; Aminosalicylic Acid; Antitubercular Agents; Clofazimine; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Male; Ofloxacin; Tuberculosis, Pulmonary	1993
Postantibiotic effects of amikacin and ofloxacin on Mycobacterium fortuitum. Antimicrobial agents and chemotherapy, 1993, Volume: 37, Issue:5 Topics: Amikacin; Colony Count, Microbial; Culture Media; Drug Administration Schedule; Humans; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Ofloxacin	1993
Spectrum of activity of levofloxacin against nontuberculous mycobacteria and its activity against the Mycobacterium avium complex in combination with ethambutol, rifampin, roxithromycin, amikacin, and clofazimine. Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:11 Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Clofazimine; Drug Combinations; Ethambutol; Humans; Levofloxacin; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium avium Complex; Ofloxacin; Rifampin; Roxithromycin	1996
Pharmacodynamic effects of antibiotics and antibiotic combinations on growing and nongrowing Staphylococcus epidermidis cells. Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:1 Topics: Amikacin; Anti-Bacterial Agents; Drug Synergism; Drug Therapy, Combination; Imipenem; Microbial Sensitivity Tests; Ofloxacin; Rifampin; Staphylococcus epidermidis; Vancomycin	1997
Successful treatment of atypical mycobacterial meningitis by fluoroquinolone. Journal of the neurological sciences, 1996, Volume: 143, Issue:1-2 Topics: Administration, Oral; Adult; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Cycloserine; Ethambutol; Humans; Injections, Spinal; Isoniazid; Male; Meningitis; Mycobacterium avium Complex; Mycobacterium Infections, Nontuberculous; Ofloxacin; Polymerase Chain Reaction; Rifampin; Streptomycin	1996
Activities of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with amikacin, against acinetobacters as determined by checkerboard and time-kill studies. Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:5 Topics: Acinetobacter; Amikacin; Anti-Infective Agents; Ciprofloxacin; Drug Combinations; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin	1997
Aetiology, cost of antimicrobial therapy and outcome in neutropenic patients who developed bacteraemia during antimicrobial prophylaxis: a case-control study. International journal of antimicrobial agents, 1998, Volume: 10, Issue:4 Topics: Amikacin; Amphotericin B; Antibiotic Prophylaxis; Bacteremia; Bacterial Infections; Case-Control Studies; Catheters, Indwelling; Ceftazidime; Drug Therapy, Combination; Enterococcus; Female; Fluconazole; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Neoplasms; Neutropenia; Ofloxacin; Retrospective Studies; Streptococcal Infections; Treatment Outcome; Vancomycin; Xanthomonas	1998
Penetration of antibiotics into the pancreas in rats: an effect of acute necrotizing pancreatitis. Scandinavian journal of gastroenterology, 1999, Volume: 34, Issue:1 Topics: Amikacin; Amoxicillin; Animals; Anti-Bacterial Agents; Cefoperazone; Clavulanic Acid; Female; Ofloxacin; Pancreas; Pancreatic Juice; Pancreatitis, Acute Necrotizing; Piperacillin; Rats; Rats, Wistar; Taurocholic Acid; Tissue Distribution	1999
Evaluation of post-antibiotic effects of antipseudomonal antibiotics using an automated system. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 2000, Volume: 108, Issue:4 Topics: 4-Quinolones; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Automation; Ceftazidime; Ciprofloxacin; Escherichia coli; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Netilmicin; Ofloxacin; Pefloxacin; Pseudomonas; Pseudomonas aeruginosa; Pseudomonas Infections	2000
In vivo activity of levofloxacin alone or in combination with imipenem or amikacin in a mouse model of Acinetobacter baumannii pneumonia. The Journal of antimicrobial chemotherapy, 2000, Volume: 46, Issue:5 Topics: Acinetobacter Infections; Amikacin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Area Under Curve; Disease Models, Animal; Drug Therapy, Combination; Female; Imipenem; Levofloxacin; Mice; Mice, Inbred C3H; Microbial Sensitivity Tests; Ofloxacin; Pneumonia, Bacterial; Thienamycins	2000
Novel treatment of meningitis caused by multidrug-resistant Mycobacterium tuberculosis with intrathecal levofloxacin and amikacin: case report. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2001, Feb-15, Volume: 32, Issue:4 Topics: Adult; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Drug Therapy, Combination; Humans; Injections, Spinal; Levofloxacin; Male; Mycobacterium tuberculosis; Ofloxacin; Tuberculosis, Meningeal; Tuberculosis, Multidrug-Resistant	2001
Population pharmacokinetics of antituberculous drugs and treatment of Mycobacterium bovis infection in bongo antelope (Tragelaphus eurycerus isaaci). Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians, 2002, Volume: 33, Issue:3 Topics: Amikacin; Animals; Antelopes; Antitubercular Agents; Area Under Curve; Ethambutol; Female; Isoniazid; Levofloxacin; Male; Mycobacterium bovis; Ofloxacin; Pyrazinamide; Rifampin; Tuberculosis	2002
In vitro sensitivity of Mycobacterium xenopi to five antibiotics. Pathologie-biologie, 2002, Volume: 50, Issue:10 Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Ethambutol; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Mycobacterium xenopi; Ofloxacin; Rifampin	2002
A comparison between disk diffusion and microdilution for susceptibility testing of Mycobacterium fortuitum complex. Journal of chemotherapy (Florence, Italy), 2002, Volume: 14, Issue:6 Topics: Amikacin; Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Colony Count, Microbial; Erythromycin; Microbial Sensitivity Tests; Mycobacterium fortuitum; Ofloxacin; Tetracycline	2002
Polymicrobial keratitis secondary to Burkholderia ambifaria, enterococcus, and staphylococcus aureus in a patient with herpetic stromal keratitis. American journal of ophthalmology, 2003, Volume: 136, Issue:4 Topics: Amikacin; Burkholderia; Burkholderia Infections; Corneal Stroma; Drug Therapy, Combination; Enterococcus; Eye Infections, Bacterial; Gram-Positive Bacterial Infections; Humans; Keratitis, Herpetic; Levofloxacin; Male; Middle Aged; Ofloxacin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin	2003
[Cefepime (maxipime) in the treatment of severe urinary tract infection]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2003, Volume: 48, Issue:7 Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Ciprofloxacin; Drug Administration Schedule; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Sensitivity and Specificity; Treatment Outcome; Urinary Tract Infections	2003
Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong, 1995-2002, after the implementation of DOTS-plus. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2004, Volume: 8, Issue:6 Topics: Amikacin; Anti-Bacterial Agents; Antitubercular Agents; Communicable Disease Control; Cycloserine; Directly Observed Therapy; Drug Combinations; Ethionamide; Hong Kong; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Population Surveillance; Program Evaluation; Recurrence; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2004
[A case of pulmonary multiresistant Mycobacterium bovis tuberculosis in Madagascar]. Archives de l'Institut Pasteur de Madagascar, 2003, Volume: 69, Issue:1-2 Topics: Amikacin; Antitubercular Agents; Capreomycin; Chronic Disease; Ciprofloxacin; Cough; DNA, Bacterial; Drug Therapy, Combination; Ethionamide; Humans; Kanamycin; Madagascar; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Mycobacterium bovis; Ofloxacin; Patient Compliance; Polymorphism, Restriction Fragment Length; Sputum; Treatment Failure; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2003
Second-line drug susceptibilities of Thai multidrug-resistant Mycobacterium tuberculosis isolates. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2005, Volume: 9, Issue:2 Topics: Amikacin; Aminosalicylic Acid; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Ethionamide; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Thailand	2005
Microbiological analysis of chronic dacryocystitis. Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists), 2005, Volume: 25, Issue:3 Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Chronic Disease; Corynebacterium diphtheriae; Dacryocystitis; Eye Infections, Bacterial; Female; Gentamicins; Humans; Lacrimal Apparatus; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Staphylococcus	2005
In vitro selection of resistance in Pseudomonas aeruginosa and Acinetobacter spp. by levofloxacin and ciprofloxacin alone and in combination with beta-lactams and amikacin. The Journal of antimicrobial chemotherapy, 2005, Volume: 56, Issue:2 Topics: Acinetobacter; Amikacin; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Levofloxacin; Microbial Sensitivity Tests; Mutation; Ofloxacin; Pseudomonas aeruginosa	2005
Antibiotic-induced release of inflammatory mediators from bacteria in experimental Klebsiella pneumoniae-induced sepsis. Folia microbiologica, 2005, Volume: 50, Issue:2 Topics: Amikacin; Animals; Anti-Bacterial Agents; Ceftazidime; Disease Models, Animal; Endotoxins; Humans; Inflammation; Klebsiella Infections; Klebsiella pneumoniae; Mice; Ofloxacin; Sepsis; Tumor Necrosis Factor-alpha	2005
In vitro and in vivo synergy of levofloxacin or amikacin both in combination with ceftazidime against clinical isolates of Pseudomonas aeruginosa. Journal of chemotherapy (Florence, Italy), 2005, Volume: 17, Issue:4 Topics: Amikacin; Animals; Ceftazidime; Disease Models, Animal; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; In Vitro Techniques; Levofloxacin; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Sensitivity and Specificity	2005
Synergistic potential of ceftazidime plus amikacin or levofloxacin against Pseudomonas aeruginosa as determined using a checkerboard and a disk diffusion technique. Diagnostic microbiology and infectious disease, 2005, Volume: 53, Issue:2 Topics: Amikacin; Anti-Infective Agents; Ceftazidime; Drug Synergism; Drug Therapy, Combination; Immunodiffusion; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa	2005
[Pelvic and abdominal actinomycosis presenting as a parietal mass]. Presse medicale (Paris, France : 1983), 2007, Volume: 36, Issue:3 Pt 1 Topics: Abdominal Abscess; Abdominal Wall; Actinomycosis; Amikacin; Amoxicillin; Anti-Bacterial Agents; Biopsy; Clavulanic Acid; Diagnosis, Differential; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Intrauterine Devices; Middle Aged; Ofloxacin; Pelvic Infection; Pelvic Inflammatory Disease; Radiography, Abdominal; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography	2007
Paratyphoid sepsis. Indian journal of pediatrics, 2007, Volume: 74, Issue:2 Topics: Adult; Amikacin; Anti-Bacterial Agents; Bottle Feeding; Breast Feeding; Cesarean Section; Female; Follow-Up Studies; Humans; India; Infusions, Intravenous; Male; Ofloxacin; Paratyphoid Fever; Pregnancy; Risk Assessment; Salmonella paratyphi A; Sepsis; Treatment Outcome	2007
In vitro evaluation of antibiotics' combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureus severe respiratory infections. BMC infectious diseases, 2007, Sep-21, Volume: 7 Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Drug Therapy, Combination; Humans; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Mutation; Ofloxacin; Pneumonia; Respiratory Tract Infections; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin	2007
Quantitative assessment of combination antimicrobial therapy against multidrug-resistant Acinetobacter baumannii. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:8 Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Anti-Infective Agents; Cefepime; Cephalosporins; Drug Antagonism; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin	2008
[Primary Salmonella vascular graft infection and conservative treatment]. Medecine et maladies infectieuses, 2008, Volume: 38, Issue:12 Topics: Aged; Amikacin; Anti-Bacterial Agents; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Blood Vessel Prosthesis; Cefotaxime; Ceftriaxone; Combined Modality Therapy; Device Removal; Drug Therapy, Combination; Femoral Artery; Humans; Laparotomy; Male; Ofloxacin; Oxacillin; Popliteal Artery; Prosthesis-Related Infections; Recurrence; Salmonella Infections; Salmonella typhimurium; Shock, Septic	2008
Sequence analyses of just four genes to detect extensively drug-resistant Mycobacterium tuberculosis strains in multidrug-resistant tuberculosis patients undergoing treatment. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:8 Topics: Amikacin; Antitubercular Agents; Bacterial Proteins; Capreomycin; DNA Gyrase; Extensively Drug-Resistant Tuberculosis; Humans; Mutation; Mycobacterium tuberculosis; Ofloxacin; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant; Uzbekistan	2009
In vitro bactericidal activity of the N-terminal fragment of the frog peptide esculentin-1b (Esc 1-18) in combination with conventional antibiotics against Stenotrophomonas maltophilia. Peptides, 2009, Volume: 30, Issue:9 Topics: Amikacin; Amphibian Proteins; Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Ceftazidime; Colistin; Drug Synergism; Humans; Kinetics; Levofloxacin; Microbial Viability; Ofloxacin; Peptide Fragments; Rana esculenta; Serum; Stenotrophomonas maltophilia	2009
Activity of amikacin, ertapenem, ciprofloxacin and levofloxacin alone and in combination against resistant nosocomial pathogens by time-kill. The West Indian medical journal, 2008, Volume: 57, Issue:2 Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Cross Infection; Drug Synergism; Drug Therapy, Combination; Ertapenem; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin	2008
Multicenter evaluation of Bactec MGIT 960 system for second-line drug susceptibility testing of Mycobacterium tuberculosis complex. Journal of clinical microbiology, 2009, Volume: 47, Issue:11 Topics: Amikacin; Antitubercular Agents; Capreomycin; Ethionamide; Humans; Levofloxacin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Reproducibility of Results; Sensitivity and Specificity; Tuberculosis	2009
Tsukamurella: an unrecognized mimic of atypical mycobacterial keratitis? The first case report. Cornea, 2010, Volume: 29, Issue:3 Topics: Actinomycetales; Actinomycetales Infections; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Corneal Ulcer; Diagnosis, Differential; Drug Therapy, Combination; Eye Infections, Bacterial; Humans; Keratoplasty, Penetrating; Male; Mycobacterium Infections; Ofloxacin; Reoperation	2010
Quantitative assessment of combination antimicrobial therapy against multidrug-resistant bacteria in a murine pneumonia model. The Journal of infectious diseases, 2010, Mar-15, Volume: 201, Issue:6 Topics: Acinetobacter baumannii; Amikacin; Animals; Anti-Bacterial Agents; Cefepime; Cephalosporins; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Lung; Mice; Ofloxacin; Pneumonia, Bacterial; Polymerase Chain Reaction; Pseudomonas aeruginosa; Random Allocation; Survival Analysis	2010
Impact of extensively drug-resistant tuberculosis on treatment outcome of multidrug-resistant tuberculosis patients with standardized regimen: report from Iran. Microbial drug resistance (Larchmont, N.Y.), 2010, Volume: 16, Issue:1 Topics: Adult; Amikacin; Anti-Bacterial Agents; Clinical Protocols; Cycloserine; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Female; Humans; Iran; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Prothionamide; Treatment Outcome; Tuberculosis, Pulmonary	2010
Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:5 Topics: Amikacin; Antitubercular Agents; Bacterial Proteins; Capreomycin; Ciprofloxacin; Ethambutol; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Rifampin	2011
In vitro activities of ceftobiprole combined with amikacin or levofloxacin against Pseudomonas aeruginosa: evidence of a synergistic effect using time-kill methodology. International journal of antimicrobial agents, 2011, Volume: 38, Issue:1 Topics: Amikacin; Anti-Bacterial Agents; Cephalosporins; Drug Synergism; Drug Therapy, Combination; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Stem Cells; Time Factors	2011
Empirical therapy with ceftazidime combined with levofloxacin or once-daily amikacin for febrile neutropenia in patients with neoplasia: a prospective comparative study. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2012, Volume: 31, Issue:7 Topics: Aged; Amikacin; Anti-Bacterial Agents; Ceftazidime; Drug Therapy, Combination; Female; Fever of Unknown Origin; Humans; Kidney Diseases; Levofloxacin; Male; Middle Aged; Neoplasms; Neutropenia; Ofloxacin; Prospective Studies; Survival Analysis; Treatment Outcome	2012
Effective antibiotics in combination against extreme drug-resistant Pseudomonas aeruginosa with decreased susceptibility to polymyxin B. PloS one, 2011, Volume: 6, Issue:12 Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Ofloxacin; Phylogeny; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Thienamycins; Time Factors	2011
Mycobacterium tuberculosis population structure determines the outcome of genetics-based second-line drug resistance testing. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:5 Topics: Amikacin; Antitubercular Agents; Bacterial Typing Techniques; Base Sequence; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Genotype; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Mycobacterium tuberculosis; Ofloxacin; Phenotype; Polymorphism, Single Nucleotide; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant	2012
Genotype MTBDRsl line probe assay shortens time to diagnosis of extensively drug-resistant tuberculosis in a high-throughput diagnostic laboratory. American journal of respiratory and critical care medicine, 2012, Dec-15, Volume: 186, Issue:12 Topics: Amikacin; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; Extensively Drug-Resistant Tuberculosis; Genetic Markers; Genotype; Humans; Microbial Sensitivity Tests; Molecular Diagnostic Techniques; Mycobacterium tuberculosis; Ofloxacin; Pentosyltransferases; Rifampin; Sensitivity and Specificity; South Africa; Sputum; Time Factors	2012
Incidence and risk factors for extensively drug-resistant tuberculosis in Delhi region. PloS one, 2013, Volume: 8, Issue:2 Topics: Adult; Amikacin; Antitubercular Agents; Capreomycin; Ethionamide; Extensively Drug-Resistant Tuberculosis; Female; Humans; Incidence; India; Isoniazid; Male; Mycobacterium tuberculosis; Ofloxacin; Prevalence; Rifampin; Risk Factors; Sputum; Tuberculosis, Pulmonary	2013
Characterization of mutations in multi- and extensive drug resistance among strains of Mycobacterium tuberculosis clinical isolates in Republic of Korea. Diagnostic microbiology and infectious disease, 2013, Volume: 76, Issue:2 Topics: Acetyltransferases; Amidohydrolases; Amikacin; Antigens, Bacterial; Bacterial Proteins; Capreomycin; Catalase; DNA Gyrase; DNA Primers; DNA-Directed RNA Polymerases; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Fluoroquinolones; Genetic Loci; Humans; Isoniazid; Kanamycin; Mutation; Mycobacterium tuberculosis; Ofloxacin; Oxidoreductases; Pentosyltransferases; Polymerase Chain Reaction; Promoter Regions, Genetic; Pyrazinamide; Republic of Korea; Rifampin; Sequence Analysis, DNA; Streptomycin; Tuberculosis, Multidrug-Resistant	2013
Impact of fluoroquinolone resistance on bactericidal and sterilizing activity of a moxifloxacin-containing regimen in murine tuberculosis. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:9 Topics: Amikacin; Animals; Antitubercular Agents; Aza Compounds; DNA Gyrase; Drug Administration Schedule; Drug Resistance, Bacterial; Ethionamide; Female; Fluoroquinolones; Mice; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Mycobacterium tuberculosis; Ofloxacin; Quinolines; Recurrence; Rodent Diseases; Survival Analysis; Tuberculosis	2013
First proficiency testing of second-line anti-tuberculosis drug susceptibility testing in 12 provinces of China. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2013, Volume: 17, Issue:11 Topics: Amikacin; Antitubercular Agents; Capreomycin; China; Drug Resistance, Bacterial; Humans; Kanamycin; Laboratory Proficiency Testing; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Observer Variation; Ofloxacin; Predictive Value of Tests; Quality Control; Quality Indicators, Health Care; Reproducibility of Results; Tuberculosis	2013
Plasma drug activity in patients on treatment for multidrug-resistant tuberculosis. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:2 Topics: Adolescent; Adult; Amikacin; Antitubercular Agents; Cycloserine; Ethionamide; Female; Fluoroquinolones; Humans; Kanamycin; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Sputum; Tanzania; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2014
Second-line drug susceptibility breakpoints for Mycobacterium tuberculosis using the MODS assay. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2014, Volume: 18, Issue:2 Topics: Amikacin; Antitubercular Agents; Capreomycin; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; India; Kanamycin; Microbial Sensitivity Tests; Microscopy; Moldova; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Peru; Predictive Value of Tests; Reproducibility of Results; South Africa; Sputum; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2014
Characterization of extensively drug-resistant Mycobacterium tuberculosis isolates circulating in Siberia. BMC infectious diseases, 2014, Sep-03, Volume: 14 Topics: Adult; Amikacin; Antitubercular Agents; Capreomycin; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Female; Genotype; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Minisatellite Repeats; Mutation; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Siberia; Tuberculosis; Young Adult	2014
Second-line anti-tuberculosis drug resistance and its genetic determinants in multidrug-resistant Mycobacterium tuberculosis clinical isolates. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2016, Volume: 49, Issue:3 Topics: Adult; Aged; Amikacin; Antitubercular Agents; Base Sequence; Capreomycin; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Ethionamide; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Mycobacterium tuberculosis; Ofloxacin; Oxidoreductases; Rifampin; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant	2016
Phylogenetic study of metallo-β-lactamase producing multidrug resistant Pseudomonas aeruginosa isolates from burn patients. Burns : journal of the International Society for Burn Injuries, 2015, Volume: 41, Issue:8 Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; Burns; Ceftazidime; Ceftriaxone; Cilastatin; Clavulanic Acid; Colistin; Disk Diffusion Antimicrobial Tests; Drug Combinations; Drug Resistance, Multiple, Bacterial; Genetic Variation; Humans; Imipenem; Minocycline; Netilmicin; Ofloxacin; Phylogeny; Polymerase Chain Reaction; Pseudomonas aeruginosa; Tigecycline	2015
Sensititre® MYCOTB MIC plate for drug susceptibility testing of Mycobacterium tuberculosis complex isolates. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2016, Volume: 20, Issue:3 Topics: Amikacin; Aminosalicylic Acid; Antitubercular Agents; China; Cycloserine; Ethambutol; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Tuberculosis	2016
Rapid diagnosis of MDR and XDR tuberculosis with the MeltPro TB assay in China. Scientific reports, 2016, 05-06, Volume: 6 Topics: Amikacin; China; Extensively Drug-Resistant Tuberculosis; Humans; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Sensitivity and Specificity; Sputum; Tuberculosis, Multidrug-Resistant	2016
Determination of MIC Breakpoints for Second-Line Drugs Associated with Clinical Outcomes in Multidrug-Resistant Tuberculosis Treatment in China. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:8 Topics: Adolescent; Adult; Aged; Amikacin; Antitubercular Agents; China; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Prospective Studies; Pyrazinamide; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult	2016
Extensively drug-resistant tuberculosis (XDR-TB) in Morocco. Journal of global antimicrobial resistance, 2017, Volume: 11 Topics: Adolescent; Adult; Aged; Amikacin; Extensively Drug-Resistant Tuberculosis; Female; Genotype; Humans; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Morocco; Mutation; Mycobacterium tuberculosis; Ofloxacin; Young Adult	2017
Molecular characterization of mutations associated with resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients from high prevalence tuberculosis city in Morocco. BMC infectious diseases, 2018, 02-27, Volume: 18, Issue:1 Topics: Amikacin; Antitubercular Agents; Base Sequence; Capreomycin; DNA Mutational Analysis; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Gene Frequency; Humans; Kanamycin; Microbial Sensitivity Tests; Morocco; Mutation; Mycobacterium tuberculosis; Ofloxacin; Prevalence; Tuberculosis, Multidrug-Resistant	2018
Multidrug resistance, prevalence and phylogenetic analysis of genes encoding class II and III integrons in clinically isolated Escherichia coli. Cellular and molecular biology (Noisy-le-Grand, France), 2018, Apr-30, Volume: 64, Issue:5 Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Base Sequence; Cefotaxime; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Gene Expression Regulation, Bacterial; Gentamicins; Hospitals; Humans; Imipenem; Integrons; Microbial Sensitivity Tests; Nalidixic Acid; Ofloxacin; Phylogeny; Polymerase Chain Reaction; Prevalence; Saudi Arabia; Sequence Alignment	2018
Use of whole-genome sequencing to predict Mycobacterium tuberculosis drug resistance in Shanghai, China. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020, Volume: 96 Topics: Adult; Amikacin; Antitubercular Agents; China; Drug Resistance, Bacterial; Ethambutol; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Streptomycin; Tuberculosis; Whole Genome Sequencing	2020
Sequence-based detection of first-line and second-line drugs resistance-associated mutations in Mycobacterium tuberculosis isolates in Isfahan, Iran. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 2020, Volume: 85 Topics: Adult; Aged; Aged, 80 and over; Amikacin; Antitubercular Agents; Capreomycin; DNA Mutational Analysis; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Genetic Variation; Genotype; Humans; Iran; Isoniazid; Kanamycin; Male; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant	2020
Use of Whole-Genome Sequencing to Predict Microbiology spectrum, 2022, 04-27, Volume: 10, Issue:2 Topics: Amikacin; Aminosalicylic Acid; Antitubercular Agents; China; Cycloserine; Drug Resistance; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant	2022
Prediction of Mycobacterium tuberculosis drug resistance by nucleotide MALDI-TOF-MS. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2022, Volume: 121 Topics: Amikacin; Antitubercular Agents; China; Drug Resistance; Ethambutol; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Nucleotides; Ofloxacin; Rifampin; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Streptomycin; Tuberculosis, Lymph Node	2022
Spatial heterogeneity of extensively drug resistant-tuberculosis in Western Cape Province, South Africa. Scientific reports, 2022, 06-27, Volume: 12, Issue:1 Topics: Amikacin; Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; South Africa; Tuberculosis, Multidrug-Resistant	2022
Variation in missed doses and reasons for discontinuation of anti-tuberculosis drugs during hospital treatment for drug-resistant tuberculosis in South Africa. PloS one, 2023, Volume: 18, Issue:2 Topics: Adult; Amikacin; Aminosalicylic Acid; Antitubercular Agents; Ethionamide; Female; HIV Infections; Hospitals; Humans; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Retrospective Studies; South Africa; Tuberculosis, Multidrug-Resistant	2023